Simplex Trading, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Simplex Trading, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$83.14 - $145.99 $216,413 - $380,011	2,603 Added 142.79%	4,426 $644,000
Q1 2022 May 02, 2022	BUY	$110.08 - $142.92 $200,675 - $260,543	1,823 New	1,823 $216,000
Q1 2021 Apr 26, 2021	SELL	$64.07 - $91.75 $1.2 Million - $1.72 Million	-18,776 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$65.07 - $98.24 $181,154 - $273,500	2,784 Added 17.41%	18,776 $1.61 Million
Q3 2020 Oct 14, 2020	BUY	$59.04 - $77.95 $944,167 - $1.25 Million	15,992 New	15,992 $1.04 Million
Q2 2020 Jul 13, 2020	SELL	$29.01 - $74.23 $126,396 - $323,420	-4,357 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$27.51 - $57.29 $119,861 - $249,612	4,357 New	4,357 $148,000
Q4 2019 Feb 05, 2020	SELL	$40.86 - $57.65 $750,761 - $1.06 Million	-18,374 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$37.38 - $49.47 $1.35 Million - $1.78 Million	-36,060 Reduced 66.25%	18,374 $766,000
Q2 2019 Jul 26, 2019	BUY	$39.79 - $67.01 $715,662 - $1.21 Million	17,986 Added 49.35%	54,434 $2.38 Million
Q1 2019 Apr 18, 2019	BUY	$34.52 - $53.29 $1 Million - $1.55 Million	29,110 Added 396.7%	36,448 $0
Q4 2018 Jan 16, 2019	BUY	$29.75 - $42.9 $93,772 - $135,220	3,152 Added 75.3%	7,338 $271,000
Q3 2018 Oct 23, 2018	BUY	$32.79 - $43.0 $40,397 - $52,976	1,232 Added 41.71%	4,186 $157,000
Q2 2018 Jul 30, 2018	SELL	$23.62 - $42.29 $470,061 - $841,613	-19,901 Reduced 87.08%	2,954 $116,000
Q1 2018 Apr 26, 2018	BUY	$22.49 - $34.56 $459,898 - $706,717	20,449 Added 849.92%	22,855 $588,000
Q4 2017 Jan 10, 2018	BUY	$20.44 - $35.56 $49,178 - $85,557	2,406	2,406 $64,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.